DORNIER MEDTECH SYSTEMS GMBH Patent applications |
Patent application number | Title | Published |
20100286574 | TREATING APPARATUS - The present invention relates to a treating apparatus which can be used with a radiation source and which can particularly be employed in lithotripsy, a shockwave source being provided which generates shockwaves and with which shockwaves can be sent to an object to be treated, and a radiation locating device being also provided which is integrated into the shockwave source. To provide a treating apparatus of this type which despite the use with a radiation source permits a high image quality and accurate focusing of the shockwaves in a way which is as easy as possible, the radiation locating device comprises a radiation receiving unit which is configured as a solid-state detector. The solid-state detector can include both radiation locating units and ultrasonic locating units. | 11-11-2010 |
20090119028 | APPARATUS AND METHOD FOR DETERMINING AIR-KERMA RATE - An apparatus for determining the air-kerma rate of an x-ray device comprises a data obtaining component for obtaining data of the x-ray device, a calculation component for calculating the air-kerma rate from the obtained data, and an outputting component for outputting the calculated air-kerma rate, where the calculation component uses an algebraic formula for the calculation of the air-kerma rate. | 05-07-2009 |
20080267927 | Methods for improving cell therapy and tissue regeneration in patients with cardiovascular diseases by means of shockwaves - Improving cell therapy and tissue regeneration in a patient suffering from a cardiovascular or a neurological disease by treating a tissue of the patient with shock waves and/or applying to the patient a therapeutically effective amount of stem cells and/or progenitor cells. Such treatment increases expression of chemoattractants, pro-angiogenic factors, and pro-survival factors. The chemoattractants can be, for example, vascular endothelial growth factor (VEGF) or stromal cell derived factor 1 (SDF-1). For example, the treated tissue can be located in the patient's heart or in a skeletal muscle of the patient, and the shock waves can be extracorporeal shock waves (ESW) or intracorporeal shock waves. The cardiovascular disease can have an ischemic or non-ischemic etiology. For example, the cardiovascular disease can be a myocardial infarction, ischemic cardiomyopathy, or a dilatative cardiomyopathy. For example, the neurological disease can be a peripheral neuropathy or neuropathic pain. | 10-30-2008 |